Press Release

<< Back

Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference

August 10, 2021

BURNABY, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in one-on-one investor meetings as well as a virtual panel discussion at the 12th Annual Wedbush PacGrow Healthcare Conference.

Panel Topic: “Got My Mind Set On You - Advancing Novel Epilepsy Targets”
Date: Wednesday, August 11, 2021
Time: 11:30 am12 pm Eastern Time
Panelist: Dr. Simon Pimstone, Executive Chair of the Board

Additional details along with a link to the live webcast can be found on the “Investors” section of Xenon’s website at When available, webcasts will be posted for replay following the event for 30 days. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Maria McClean
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353

Primary Logo

Source: Xenon Pharmaceuticals Inc.